Bristol-Myers Slides After FDA Delays Marketing Approval for Cancer Therapy - TheStreet.com

Bristol-Myers Slides After FDA Delays Marketing Approval for Cancer Therapy - TheStreet.com | marketing - Google News | October 22, 2018 at 08:15AM

TheStreet.com

Bristol-Myers Slides After FDA Delays Marketing Approval for Cancer Therapy TheStreet.com Bristol-Myers said the marketing application for its Opdivo plus Yervoy cancer therapy combination will be delayed by three months, until May 2019. EU regulators asked for more information on the therapy, which is being tested as part of a trial the ... and more »

October 22, 2018 at 08:15AM | marketing - Google News
Bristol-Myers Slides After FDA Delays Marketing Approval for Cancer Therapy - TheStreet.com
marketing - Google News